Sei Investments CO Novo Nordisk A S Transaction History

Sei Investments CO

$66.7 Billion
Q1 2024

A detailed history of Sei Investments CO transactions in Novo Nordisk A S stock. As of the latest transaction made, Sei Investments CO holds 754,776 shares of NVO stock, worth $108 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

754,776

Previous 807,438 6.52%

Holding current value

$108 Million

Previous $83.5 Million 16.02%

% of portfolio

0.15%

Previous 0.14%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$102.11 - $135.92 $5.38 Million - $7.16 Million	-52,662 Reduced 6.52%	754,776 $96.9 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $2.52 Million - $3.03 Million	28,723 Added 3.69%	807,438 $83.5 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $48.9 Million - $107 Million	537,582 Added 222.94%	778,715 $70.8 Million
Q2 2023 Aug 11, 2023	BUY	$155.98 - $172.65 $2.26 Million - $2.5 Million	14,471 Added 6.38%	241,133 $39 Million
Q1 2023 May 12, 2023	BUY	$132.34 - $159.14 $685,785 - $824,663	5,182 Added 2.34%	226,662 $36.1 Million

Q4 2022 Feb 10, 2023	BUY	$102.55 - $135.33 $2.8 Million - $3.7 Million	27,318 Added 14.07%	221,480 $30 Million
Q3 2022 Nov 14, 2022	SELL	$95.28 - $116.93 $1.34 Million - $1.65 Million	-14,090 Reduced 6.77%	194,162 $19.3 Million
Q2 2022 Aug 15, 2022	BUY	$103.24 - $121.81 $10.4 Million - $12.3 Million	101,077 Added 94.31%	208,252 $23.1 Million
Q1 2022 May 13, 2022	BUY	$93.1 - $112.54 $1.49 Million - $1.8 Million	15,996 Added 17.54%	107,175 $11.9 Million
Q4 2021 Feb 14, 2022	SELL	$95.88 - $117.08 $252,260 - $308,037	-2,631 Reduced 2.8%	91,179 $10.2 Million
Q3 2021 Nov 12, 2021	SELL	$84.42 - $106.62 $1.52 Million - $1.92 Million	-17,990 Reduced 16.09%	93,810 $9.01 Million
Q2 2021 Aug 06, 2021	BUY	$67.66 - $84.76 $1.98 Million - $2.48 Million	29,289 Added 35.5%	111,800 $9.37 Million
Q1 2021 May 12, 2021	SELL	$67.06 - $75.82 $1.31 Million - $1.48 Million	-19,469 Reduced 19.09%	82,511 $5.56 Million
Q4 2020 Feb 08, 2021	SELL	$63.89 - $73.8 $769,555 - $888,921	-12,045 Reduced 10.56%	101,980 $7.12 Million
Q3 2020 Dec 04, 2020	SELL	$63.69 - $70.22 $589,323 - $649,745	-9,253 Reduced 7.51%	114,025 $7.92 Million
Q3 2020 Nov 06, 2020	SELL	$63.69 - $70.22 $1.14 Million - $1.26 Million	-17,936 Reduced 12.7%	123,278 $8.56 Million
Q2 2020 Aug 17, 2020	SELL	$58.54 - $67.94 $1.29 Million - $1.5 Million	-22,094 Reduced 13.53%	141,214 $9.25 Million
Q2 2020 Aug 11, 2020	BUY	$58.54 - $67.94 $306,164 - $355,326	5,230 Added 3.31%	163,308 $9.51 Million
Q1 2020 May 14, 2020	BUY	$49.46 - $64.78 $39,716 - $52,018	803 Added 0.51%	158,078 $9.52 Million
Q4 2019 Feb 06, 2020	SELL	$49.86 - $58.26 $1.07 Million - $1.25 Million	-21,534 Reduced 12.04%	157,275 $9.1 Million
Q3 2019 Nov 12, 2019	SELL	$47.54 - $53.43 $491,611 - $552,519	-10,341 Reduced 5.47%	178,809 $9.24 Million
Q2 2019 Aug 14, 2019	SELL	$46.79 - $52.47 $320,885 - $359,839	-6,858 Reduced 3.5%	189,150 $9.66 Million
Q1 2019 May 15, 2019	BUY	$46.36 - $52.63 $7.72 Million - $8.76 Million	166,457 Added 563.29%	196,008 $10.3 Million
Q4 2018 Feb 13, 2019	BUY	$41.54 - $47.25 $20,770 - $23,625	500 Added 1.72%	29,551 $1.39 Million
Q3 2018 Nov 08, 2018	SELL	$46.76 - $51.24 $2.7 Million - $2.95 Million	-57,647 Reduced 66.49%	29,051 $1.37 Million
Q2 2018 Aug 03, 2018	SELL	$44.29 - $50.42 $646,678 - $736,182	-14,601 Reduced 14.41%	86,698 $4 Million
Q1 2018 May 11, 2018	BUY	$48.49 - $58.14 $399,751 - $479,306	8,244 Added 8.86%	101,299 $4.99 Million
Q4 2017 Feb 08, 2018	BUY	$47.53 - $53.73 $3.54 Million - $4.01 Million	74,546 Added 402.76%	93,055 $4.99 Million
Q3 2017 Nov 06, 2017	BUY	$41.15 - $49.22 $761,645 - $911,012	18,509	18,509 $891,000

Others Institutions Holding NVO

# of Institutions

1,854

Shares Held

309M

Call Options Held

5.29M

Put Options Held

4.93M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $322B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account

Sei Investments CO Novo Nordisk A S Transaction History